Navigation Links
Minimally Invasive Devices Adds $2.5 Million to its Series B

COLUMBUS, Ohio, June 17, 2013 /PRNewswire/ -- Minimally Invasive Devices, Inc. (MID) today announced it has raised an additional $2.5 million from Radius Ventures, topping off its Series B financing at $11.5 million. The Series B originally raised $9 million in a financing led by Canaan Partners with participation by existing investor, Charter Life Sciences.

FloShield™, MID's flagship laparoscopic vision system is the first and only product that actually maintains a clear field of vision from beginning-to-end in laparoscopic surgery procedures. FloShield technology easily attaches to modern HD vision systems, enabling surgery to occur without interruption, loss of vision, or the need to remove the scope for cleaning. Such removals are time consuming, interfere with the focus of the operative team, and frequently occur during critical points in surgery when optimal vision is critical, leading to surgeon frustration.

"Currently, surgeons will lose vision and need to stop surgery to clean the lens externally as often as ten times per hour," said Wayne Poll, MD, founder and CEO of MID. "We believe that surgeons will appreciate and value the benefits of a consistently clear view and will come to expect this as a standard, without nostalgia for the days they needed to clean the lens constantly when vision was lost."

FloShield produces an air vortex to form an invisible protective barrier over the lens, preventing debris and fogging. This system is augmented by the Flo-X lens wash, a biocompatible surfactant that will flush the lens inside the body if needed.  Generation III FloShield is now launching, which improves further upon the system's in situ flush capabilities.

Funds will be used for sales and marketing, clinical studies, the generation of outcomes data and additional product development.

Jordan Davis, Managing Partner of Radius Ventures commented, "FloShield has hit a bullseye in delivering on the number one need of all laparoscopic surgeons – that is, avoiding loss of vision due to debris and fogging of the lens, particularly during long, complex procedures.  No other technology to date has been able to achieve a continual, clear field of vision throughout such procedures, enabling surgeons to remain in control, maximizing operating room efficiency and potentially safety." 

About Minimally Invasive Devices, Inc.

Minimally Invasive Devices, Inc. (MID) has developed and manufactures the FloShield™ laparoscopic vision system, the first device that prevents loss of vision during laparoscopic surgery due to obscuration of the optics.

About Radius Ventures, LLC

Founded in 1997, Radius Ventures is a venture capital firm that invests in expansion-stage health and life sciences companies. Radius has a deep understanding of the complexities and opportunities that drive successful health and life sciences investing. The firm's goal is to identify companies on the cusp of major value creation with the objective of achieving liquidity within a three- to five-year time frame. Central to the firm's investment strategy is providing growth capital to well-managed companies addressing large markets with attractive adoption dynamics.  Ideal investment candidates are capital efficient with scalable business models and compelling value propositions.  For more information visit

Company Contact:
Wayne Poll

Media Contact:
Carolyn Hawley
Canale Communications

SOURCE Minimally Invasive Devices, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
2. US Minimally Invasive Spine Technology Market to Grow Strongly to $2 Billion by 2017
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
5. Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer
6. A non-invasive method to track Huntingtons disease progression
7. The American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee Recommend Noninvasive Prenatal Testing for Fetal Aneuploidy
8. MonaVie Introduces Non-Invasive Technology Device to Measure Antioxidant Levels in the Body
9. Non Invasive Bed Bug Treatments Offered to a State Library Shutdown Due to Sightings of Bed Bugs, Details the Treatments' Process
10. Non-Invasive Rust Remover Clears Rust Without Use of Chemicals, My Cleaning Products Dishes Out Samples of It to Prove It Works
11. Three-Step Rust Removal With a Non-Invasive Rust Remover Published by My Cleaning Products, MCP Offers Sample of the Product
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
(Date:11/24/2015)... 24, 2015 /CNW Telbec/ - ProMetic Life Sciences Inc. (TSX: ... Mr. Pierre Laurin , President and Chief Executive Officer ... upcoming Piper Jaffray 27 th Annual Healthcare Conference to ... 1-2, 2015. st , at 8.50am (ET) ... throughout the day. The presentation will be available live via ...
(Date:11/24/2015)... ... , ... Whitehouse Laboratories is pleased to announce that it has completed construction ... dedicated to basic USP 61, USP 62 and USP 51 testing specific to raw ... and micro testing performed by one supplier. Management has formally announced that ...
(Date:11/23/2015)... , ... November 23, 2015 , ... ... for the development of its Nexera UC Unified Chromatography system. The award from ... technically significant new products of the year in the analytical and testing category. ...
Breaking Biology Technology:
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/12/2015)... , Nov. 11, 2015   Growing ... reliable analytical tools has been paving the way ... qualitative determination of discrete analytes in clinical, agricultural, ... are being predominantly used in medical applications, however, ... environmental sectors due to continuous emphasis on improving ...
Breaking Biology News(10 mins):